Four RPB-supported researchers and a Scientific Advisory Panel member have been honored with the prestigious 2018 António Champalimaud Vision Award for their groundbreaking research
RPB and AUPO announce 2018 recipient of David F. Weeks Award for outstanding AMD research.
The first patient receives an FDA-approved gene therapy for inherited retinal disease at Mass. Eye and Ear.
Award recipients to use IRIS Registry database to conduct population-based studies.
Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.
RPB-supported researchers at the University of Southern California Roski Eye Institute conducted the human trial.
|General Info||Research Scientists & Grantees||Eye Care Specialists||Donors & Partners|